Shiro Ikegawa Selected Research

Inborn Genetic Diseases (Disease, Hereditary)

1/2022	Identification of six novel variants from nine Chinese families with hypophosphatemic rickets.
4/2013	Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shiro Ikegawa Research Topics

Disease

16	Osteoarthritis 01/2023 - 02/2005
7	Osteochondrodysplasias (Spondyloepiphyseal Dysplasia) 08/2022 - 01/2003
6	Osteoporosis 12/2023 - 10/2007
4	Scoliosis 11/2023 - 06/2011
4	Knee Osteoarthritis 09/2009 - 01/2006
3	Pain (Aches) 08/2023 - 01/2002
3	Neoplasms (Cancer) 01/2023 - 07/2002
3	Heterotopic Ossification (Ectopic Ossification) 10/2022 - 01/2002
3	Inflammation (Inflammations) 07/2021 - 03/2009
3	Intervertebral Disc Displacement (Herniated Disc) 01/2018 - 12/2007
3	Intervertebral Disc Degeneration 07/2017 - 11/2013
3	Retinal Degeneration 01/2016 - 10/2011
3	Diastrophic dysplasia 04/2010 - 06/2006
3	Metabolic Bone Diseases (Osteopenia) 10/2009 - 01/2008
3	Myocardial Infarction 03/2009 - 01/2006
2	Disease Susceptibility (Diathesis) 01/2024 - 11/2023
2	Rickets (Rachitis) 12/2023 - 06/2019
2	Ossification of the posterior longitudinal ligament of the spine 01/2023 - 01/2002
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2020
2	Synovitis 07/2022 - 01/2021
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 04/2013
2	Desbuquois syndrome 01/2020 - 01/2017
2	Joint Instability (Joint Laxity) 01/2017 - 12/2011
2	of childhood progressive pseudorheumatoid Arthropathy 01/2016 - 01/2016
2	Torrance Type Platyspondylic Lethal Skeletal Dysplasia 12/2015 - 06/2011
2	Joint Diseases (Joint Disease) 08/2015 - 01/2008
2	Pyle disease 04/2015 - 01/2007
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 10/2013 - 10/2011
2	Cartilage-hair hypoplasia 11/2007 - 12/2003
2	Camurati-Engelmann Syndrome (Progressive Diaphyseal Dysplasia) 10/2007 - 01/2002
2	Hip Osteoarthritis (Coxarthrosis) 04/2007 - 07/2002
2	Pseudoachondroplasia 08/2004 - 01/2003
2	Retinoblastoma (Glioblastoma, Retinal) 07/2002 - 05/2002
1	Pediatric Obesity 12/2023
1	Osteopetrosis 01/2023
1	Joint Dislocations 08/2022
1	Spondylosis 08/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022
1	Hypophosphatemic Rickets 01/2022
1	Congenital Abnormalities (Deformity) 01/2022
1	Autosomal Recessive 7 Osteopetrosis 01/2022
1	Osteonecrosis (Kienbock's Disease) 01/2022
1	Hypersensitivity (Allergy) 07/2021
1	Developmental Bone Diseases (Bone Dysplasia) 06/2021
1	Dysosteosclerosis 04/2021
1	Osteophyte 01/2021
1	Osteomalacia 06/2019
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 06/2019
1	Osteoporotic Fractures 01/2019

Drug/Important Bio-Agent (IBA)

16	Proteins (Proteins, Gene)FDA Link 08/2022 - 07/2002
6	Collagen Type II (Type II Collagen)IBA 01/2016 - 08/2003
4	CollagenIBA 07/2022 - 07/2002
4	Aspartic Acid (Aspartate)FDA Link 02/2011 - 02/2005
3	Protein Isoforms (Isoforms)IBA 01/2023 - 08/2008
3	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2007
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 05/2002
3	GlycosaminoglycansIBA 01/2020 - 04/2013
3	EnzymesIBA 01/2017 - 04/2013
3	Proteoglycans (Proteoglycan)IBA 04/2013 - 06/2006
3	Sulfate TransportersIBA 04/2010 - 06/2006
3	Transforming Growth Factor beta (TGF-beta)IBA 06/2005 - 01/2002
2	Estrogens (Estrogen)FDA Link 01/2024 - 11/2023
2	Untranslated RNA (Noncoding RNA)IBA 01/2023 - 01/2006
2	Carbohydrate SulfotransferasesIBA 08/2022 - 11/2013
2	Phosphates (Orthophosphate)IBA 01/2022 - 06/2019
2	Tuberculin (PPD)IBA 01/2016 - 01/2016
2	DNA (Deoxyribonucleic Acid)IBA 10/2013 - 04/2011
2	ThrombospondinsIBA 02/2013 - 01/2008
2	Alkaline PhosphataseIBA 02/2011 - 01/2002
2	5' Untranslated Regions (5' UTR)IBA 05/2008 - 04/2007
2	Factor V (Coagulation Factor V)IBA 01/2008 - 10/2007
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2008 - 10/2004
2	Transforming Growth Factor-beta Type II ReceptorIBA 04/2007 - 08/2006
2	Transforming Growth Factor-beta Type I ReceptorIBA 04/2007 - 08/2006
2	von Willebrand FactorIBA 07/2005 - 11/2004
2	Cartilage Oligomeric Matrix ProteinIBA 08/2004 - 01/2003
1	25-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA 12/2023
1	25-hydroxyvitamin DIBA 12/2023
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2023
1	Androgen Receptors (Androgen Receptor)IBA 01/2023
1	AcidsIBA 01/2023
1	Vitamin A (Retinol)FDA LinkGeneric 10/2022
1	Protein Tyrosine PhosphatasesIBA 07/2022
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 07/2022
1	SHP099IBA 07/2022
1	SteroidsIBA 01/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 07/2021
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 07/2021
1	andrographolideIBA 07/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2021
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2021
1	CationsIBA 01/2021
1	Capsaicin (Zostrix)FDA Link 01/2021
1	Fibroblast Growth Factor-23IBA 06/2019
1	Indicators and Reagents (Reagents)IBA 01/2019

Therapy/Procedure

2	Intra-Articular Injections 07/2022 - 01/2021
1	Hip Replacement Arthroplasty (Total Hip Replacement) 08/2023
1	Punctures 08/2022
1	Aftercare (After-Treatment) 07/2021
1	Therapeutics 01/2021